Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
< Previous
1
2
3
4
5
6
7
8
9
Next >
Hepion Pharma Shares Encouraging Biomarker Data From NASH Trial
September 13, 2021
Tickers
HEPA
Tags
General
Market News
News
From
Benzinga
RedHill Biopharma To Test Its Oral Antiviral In COVID-19 Patients In South Africa
September 13, 2021
Tickers
RDHL
Tags
News
Market News
COVID/19 Coronavirus
From
Benzinga
Why Are Leap Therapeutics Shares Trading Higher On Monday?
September 13, 2021
Tickers
BGNE
LPTX
Tags
BGNE
General
why it's moving
From
Benzinga
Mimedx Stock Plunges After Disappointing Data From Musculoskeletal Trials
September 13, 2021
Tickers
MDXG
Tags
Movers
Phase 3 Trial
Phase 2 Trial
From
Benzinga
BELLUS Health Stock Shines After Refractory Chronic Cough Trial Data
September 13, 2021
Tickers
BLU
Tags
Penny Stocks
BLU
Biotech
From
Benzinga
Matinas BioPharma Stock Jumps After Meningitis Candidate Data
September 13, 2021
Tickers
MTNB
Tags
MTNB
Biotech
Penny Stocks
From
Benzinga
Why Are Hepion Pharma Shares Moving Higher Premarket Monday?
September 13, 2021
Tickers
HEPA
Tags
Briefs
HEPA
Trading Ideas
From
Benzinga
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
Tickers
FRX
IPO
IPOS
JNJ
Tags
Health Care
Briefs
Offerings
From
Benzinga
Adagio Therapeutics To Expand Late-Stage COVID-19 Antibody Trial
September 10, 2021
Tickers
ADGI
Tags
Phase 2 Trial
Biotech
Health Care
From
Benzinga
Zynerba Stock Moves Higher On Long-Term Zygel Data In Autistic Children
September 09, 2021
Tickers
ZYNE
Tags
Benzinga
Autism
Briefs
From
Benzinga
Eloxx Stock Moves Higher On Fast Track Tag For Cystic Fibrosis Candidate
September 09, 2021
Tickers
ELOX
Tags
ELOX
Benzinga
Health Care
From
Benzinga
Centessa Stock Surges On Positive Data From Hemophilia Candidate
September 09, 2021
Tickers
CNTA
Tags
Health Care
Trading Ideas
Briefs
From
Benzinga
Amgen Reveals Post-Hoc Data For Its KRAS Inhibitor In Lung Cancer Patients
September 09, 2021
Tickers
AMGN
Tags
Phase 2 Trial
AMGN
Briefs
From
Benzinga
AIM ImmunoTech To Test Ampligen In Post-COVID-19 Cognitive Dysfunction
September 08, 2021
Tickers
AIM
Tags
General
Benzinga
COVID/19 Coronavirus
From
Benzinga
Pliant Stock Moves Higher On Positive Data From Pulmonary Fibrosis Trial
September 07, 2021
Tickers
PLRX
Tags
Small Cap
Benzinga
Health Care
From
Benzinga
Why Innate Pharma Shares Are Rising On Friday?
September 03, 2021
Tickers
AZN
AZNCF
IPHA
Tags
Long Ideas
Market News
News
From
Benzinga
Novartis Stops Iscalimab Trial In Kidney Transplant Patients
September 03, 2021
Tickers
NVS
Tags
Phase 2 Trial
NVS
Briefs
From
Benzinga
Atossa To Conduct Endoxifen Mid-Stage Study In Sweden
September 02, 2021
Tickers
ATOS
Tags
General
Market News
News
From
Benzinga
Adamis Stock Jumps As Its Oral COVID-19 Drug Trial Starts Dosing
September 02, 2021
Tickers
ADMP
Tags
Benzinga
Trading Ideas
Health Care
From
Benzinga
Assembly Bio Stock Tumbles On Discontinuation Of Hepatitis B Trial
September 02, 2021
Tickers
ASMB
Tags
General
Market News
News
From
Benzinga
Pfizer Commences Dosing In Pivotal Oral COVID-19 Drug Trial
September 01, 2021
Tickers
MRK
PFE
Tags
News
Market News
COVID/19 Coronavirus
From
Benzinga
What Leerink, Wainwright Have To Say For This Alzheimer's Focused Firm
August 31, 2021
Tickers
ACIU
Tags
Biotech
Analyst Color
Price Target
From
Benzinga
See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate
August 31, 2021
Tickers
ACIU
RHHBF
RHHBY
RHHVF
Tags
Briefs
Health Care
Trading Ideas
From
Benzinga
Johnson & Johnson Stops HIV Vaccine Trial In African Women
August 31, 2021
Tickers
JNJ
Tags
Market News
News
JNJ
From
Benzinga
NRx Pharma Stock Is Moving Higher On COVID-19 Candidate Data
August 30, 2021
Tickers
NRXP
Tags
Phase 2 Trial
Movers
NRXP
From
Benzinga
Edesa Biotech Provides Update For COVID-19 Antibody Trial
August 26, 2021
Tickers
EDSA
Tags
Biotech
Penny Stocks
General
From
Benzinga
ADC Therapeutics Announces $325M Financing Agreement With HealthCare Royalty
August 26, 2021
Tickers
ADCT
Tags
Market News
ADCT
News
From
Benzinga
FibroGen's Roxadustat Aces Chemo-Induced Anemia Trial
August 25, 2021
Tickers
FGEN
Tags
Phase 2 Trial
Health Care
Briefs
From
Benzinga
Rafael Starts Mid-Stage Biliary Tract Cancer Trial With CPI-613 Combo Regime
August 25, 2021
Tickers
RFL
Tags
Small Cap
Benzinga
RFL
From
Benzinga
Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial
August 25, 2021
Tickers
LPCN
Tags
Health Care
Trading Ideas
Briefs
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.